News
Client MNRs and Landing Pages
Since 2004, brands have counted on Cision’s MultiVu to create and distribute their important news and marketing content to the world.
Let's talkSearch our recent client collaborations below:
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Oct 16, 2023Introducing “Extra Helpings,” Chick-fil-A’s First-Ever Cookbook Inspired by the Chick-fil-A Shared Table ProgramToday Chick-fil-A, Inc. released its first cookbook to raise awareness of food insecurity and the importance of reducing food waste....
Oct 16, 2023LE BLOCBUSTER FOREST HILL FÊTE SES 1 AN D’EXISTENCE : L’OFFRE ESCALADE NE CESSE DE GRIMPER EN ÎLE-DE-FRANCESituée au 11 rue Exelmans (à proximité du château) dans le complexe Forest Hill, cette salle de bloc d’une superficie de 2000 m2 et 8m de hauteur sous plafo...
Oct 16, 2023Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid EpidemicToday, Emergent BioSolutions Inc. (NYSE: EBS) announced it is teaming up with football icon, Emmitt Smith, to break down the stigma around opioid use....
Oct 16, 2023Der 45-minütige Dokumentarfilm „Verführerische Liaison – Wenn Hotpot auf Schokolade trifft" ist eine Koproduktion...
Oct 15, 2023EISAI PRESENTS NEW LEQEMBI® (LECANEMAB-IRMB) INVESTIGATIONAL SUBCUTANEOUS FORMULATION INTERIM STUDY RESULTS AND CLINICAL IMPROVEMENT DATA IN EARLIER STAGES OF EARLY ALZHEIMER’S DISEASE FROM ADDITIONAL ANALYSES OF CLARITY AD AT THE CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD) CONFERENCEEisai Co. Ltd (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”)present new data from the phase 3 Clarity AD study for its Alzheimer’s disease treatment LEQEMBI®...
Connect with us: